课题基金 / 基金详情

项目摘要

项目成果

HARALD PAGANETTI的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):由于质子治疗已加入放射治疗的主流,蒙特卡罗模拟(MC)已成为推动高度准确剂量输送的研究引擎。在上一个融资周期开发的TOPAS粒子模拟工具,使MC前所未有地易于使用。随着放射治疗推向下一个挑战,物理学和生物学走到一起,TOPAS将弥合这两个研究领域之间的鸿沟。TOPAS可以通过任何类型的治疗头跟踪任何类型的粒子,导入患者几何形状,评分剂量,通量等,具有先进的图形和评分功能,并且是完全四维的,可以处理模拟的所有时间依赖方面。研究物理学家使用TOPAS来改进质子输送系统,以实现更安全,更有效的治疗,轻松设置和运行复杂的MC模拟,而这些模拟通常需要MC专家数月的准备时间。临床物理学家使用TOPAS来优化治疗比例,模拟患者特定的治疗计划,并在 按下按钮我们将为放射生物学界带来同样的好处。在放射生物学研究以前遭受物理学家和生物学家之间的跨学科合作不足,TOPAS将弥合差距。TOPAS将让生物学家研究他们实验的详细物理方面,并让物理学家在临床上使用最新的放射生物学结果。TOPAS将为质子治疗设施、生物实验室和大学提供一个共同的研究平台。具体目标1:扩展TOPAS以促进器官效应生物学的研究。为肿瘤和正常组织结果建模提供框架B。通过复制质子束正常组织并发症的已发表数据,具体目标2:扩展TOPAS以促进细胞效应生物学的研究。为细胞效应RBE建模提供框架B。通过计算质子束的相对生物学效应,具体目标3:扩展TOPAS以促进亚细胞效应生物学的研究。为亚细胞效应机制建模提供框架B。通过复制电离频率和DNA损伤的数据进行验证具体目标4:支持和共享TOPAS为所有用户社区a.支持当前质子治疗物理学领域的TOPAS用户社区B。接触其他治疗方式和成像的新用户社区。持续的软件创新,增强的图形用户界面及其他
英文摘要
DESCRIPTION (provided by applicant): As proton therapy has joined the mainstream of radiation treatment, Monte Carlo simulation (MC) has been the research engine driving highly accurate dose delivery. The TOPAS Tool for Particle Simulation, developed in the previous funding cycle, makes MC accessible as never before. As radiation therapy pushes to the next challenge, where physics and biology come together, TOPAS will bridge the divide between these two research domains. TOPAS can track any kind of particle through any kind of treatment head, import a patient geometry, score dose, fluence, etc., has advanced graphics and scoring features, and is fully four-dimensional to handle all time-dependent aspects of a simulation. Research physicists use TOPAS to improve proton delivery systems towards safer and more effective treatments, easily setting up and running complex MC simulations that used to take MC specialists months to prepare. Clinical physicists use TOPAS to optimize the therapeutic ratio, simulating patient- specific treatment plans with the full accuracy of MC at the touch of a button. We will bring the same benefits to the radiobiological community. Where radiobiology research has previously suffered from insufficient interdisciplinary collaboration between physicists and biologists, TOPAS will bridge the gap. TOPAS will let biologists study detailed physics aspects of their experiments and let physicists employ the latest radiobiology results in the clinic. TOPAS will provide a common research platform to proton therapy facilities, biology laboratories and universities. Specific Aim 1: Expand TOPAS to facilitate research on organ effect biology a. Provide a framework for tumor and normal tissue outcome modeling b. Validate by reproducing published data on proton beam normal tissue complications Specific Aim 2: Expand TOPAS to facilitate research on cellular effect biology a. Provide a framework for cellular effect RBE modeling b. Validate by calculating the relative biological effectiveness f proton beams Specific Aim 3: Expand TOPAS to facilitate research on sub-cellular effect biology a. Provide a framework for sub-cellular effect mechanistic modeling b. Validate by reproducing data on ionization frequencies and DNA damage Specific Aim 4: Support and share TOPAS for all user communities a. Support current TOPAS user communities in proton therapy physics b. Reach out to new user communities in other therapy modalities and imaging c. Continuing software innovation, enhanced graphical user interfaces and beyond
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1088/0031-9155/57/10/2829
发表时间: 2012-05-21
期刊: Physics in medicine and biology
影响因子: 3.5
作者: [Dowdell SJ, Clasie B, Depauw N, Metcalfe P, Rosenfeld AB, Kooy HM, Flanz JB, Paganetti H]
通讯作者: Paganetti H
DOI: 10.1088/0031-9155/57/11/3295
发表时间: 2012-06-07
期刊: Physics in medicine and biology
影响因子: 3.5
作者: [Shin J, Perl J, Schümann J, Paganetti H, Faddegon BA]
通讯作者: Faddegon BA
DOI: 10.1088/0031-9155/60/13/5037
发表时间: 2015-07-07
期刊: Physics in medicine and biology
影响因子: 3.5
作者: [Ramos-Méndez J, Perl J, Schümann J, Shin J, Paganetti H, Faddegon B]
通讯作者: Faddegon B
DOI: 10.1088/0031-9155/60/13/5019
发表时间: 2015-07-07
期刊: Physics in medicine and biology
影响因子: 3.5
作者: [Méndez JR, Perl J, Schümann J, Shin J, Paganetti H, Faddegon B]
通讯作者: Faddegon B
Project 1: Understanding normal tissue toxicity to identify patients most likely to benefit from proton therapy.
  • 批准号:
    10270305
  • 项目类别:
  • 资助金额:
    $65.84万
  • 财政年份:
    2021
  • 负责人:
    HARALD PAGANETTI
  • 依托单位:
Project 1: Understanding normal tissue toxicity to identify patients most likely to benefit from proton therapy.
  • 批准号:
    10491847
  • 项目类别:
  • 资助金额:
    $56.33万
  • 财政年份:
    2021
  • 负责人:
    HARALD PAGANETTI
  • 依托单位:
Fast Individualized Delivery Adaptation in Proton Therapy
  • 批准号:
    10379929
  • 项目类别:
  • 资助金额:
    $29.81万
  • 财政年份:
    2019
  • 负责人:
    HARALD PAGANETTI
  • 依托单位:
Fast Individualized Delivery Adaptation in Proton Therapy
  • 批准号:
    10595078
  • 项目类别:
  • 资助金额:
    $30.04万
  • 财政年份:
    2019
  • 负责人:
    HARALD PAGANETTI
  • 依托单位:
海外基金